Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.09 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |